Celcuity Inc. SEC filings CELC

Celcuity Inc. has 541 filings in SEC EDGAR's recent list, going back to Mar 24, 2014. Its latest annual report, Form ARS, was filed on Apr 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Celcuity Inc. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 2, 2026 Oct 1, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 30, 2026 Sep 30, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 26, 2026 Aug 26, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K/A Amended current report
Regulation FD disclosure, Other events
Jul 15, 2026 Jul 14, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 15, 2026 Jul 14, 2026
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Jun 8, 2026 Jun 3, 2026
424B5 Prospectus supplement Jun 5, 2026 —
305B2 Filing Jun 5, 2026 —
FWP Free writing prospectus Jun 4, 2026 —
424B5 Prospectus supplement Jun 3, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2026 Jun 2, 2026
8-K/A Amended current report
Officer or director change
May 20, 2026 Feb 11, 2026
S-8 Employee stock plan registration May 18, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 18, 2026 May 18, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
8-K Current report
Regulation FD disclosure, Other events
May 1, 2026 May 1, 2026
ARS Annual report to shareholders Apr 2, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 2, 2026 —
DEF 14A Proxy statement Apr 2, 2026 Apr 2, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 25, 2026 Mar 25, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 12, 2026 Feb 11, 2026
S-3ASR Automatic shelf registration Jan 9, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Nov 17, 2025 Nov 17, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 20, 2025 Oct 18, 2025
D/A Filing Sep 23, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
Sep 10, 2025 Sep 9, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Material agreement, New debt, Other events
Aug 1, 2025 Jul 30, 2025
305B2 Filing Jul 31, 2025 —
8-K Current report
Material agreement, Other events
Jul 31, 2025 Jul 30, 2025
424B5 Prospectus supplement Jul 31, 2025 —
424B5 Prospectus supplement Jul 31, 2025 —
FWP Free writing prospectus Jul 30, 2025 —
FWP Free writing prospectus Jul 30, 2025 —
424B5 Prospectus supplement Jul 29, 2025 —
8-K Current report
Material agreement, Other events
Jul 29, 2025 Jul 28, 2025
424B5 Prospectus supplement Jul 28, 2025 —
424B5 Prospectus supplement Jul 28, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jul 28, 2025 Jul 28, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 30, 2025 Jun 30, 2025
S-8 Employee stock plan registration Jun 4, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
May 16, 2025 May 13, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
ARS Annual report to shareholders Apr 1, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 1, 2025 —
DEF 14A Proxy statement Apr 1, 2025 Apr 1, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Other events
Dec 6, 2024 Dec 6, 2024
424B5 Prospectus supplement Dec 6, 2024 —
EFFECT Filing Dec 2, 2024 —
CORRESP Letter to the SEC Nov 27, 2024 —
S-3/A Filing Nov 26, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
D/A Filing Oct 15, 2024 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results, Other events
Oct 9, 2024 Oct 7, 2024
UPLOAD Letter from the SEC Sep 6, 2024 —
S-3 Shelf registration Aug 30, 2024 —
DEFA14A Additional proxy material Aug 28, 2024 —
DEF 14A Proxy statement Aug 28, 2024 Aug 28, 2024
PRE 14A Preliminary proxy statement Aug 16, 2024 Aug 16, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
D/A Filing Jun 28, 2024 —
8-K Current report
Material agreement, Other events
May 31, 2024 May 30, 2024
424B5 Prospectus supplement May 30, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
May 30, 2024 May 30, 2024
S-8 Employee stock plan registration May 20, 2024 —
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 13, 2024 May 9, 2024
D/A Filing Apr 25, 2024 —
8-K Current report
Material agreement, New debt
Mar 29, 2024 Mar 29, 2024
ARS Annual report to shareholders Mar 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Mar 28, 2024 —
DEF 14A Proxy statement Mar 28, 2024 Mar 28, 2024
10-K Annual report Mar 27, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 27, 2024 Mar 27, 2024
8-K Current report
Other events
Dec 5, 2023 Dec 1, 2023
424B3 Prospectus Nov 29, 2023 —
EFFECT Filing Nov 28, 2023 —
D/A Filing Nov 27, 2023 —
D/A Filing Nov 27, 2023 —
CORRESP Letter to the SEC Nov 24, 2023 —
S-3/A Filing Nov 22, 2023 —
UPLOAD Letter from the SEC Nov 21, 2023 —
S-3 Shelf registration Nov 14, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
D Filing Oct 26, 2023 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 23, 2023 Oct 18, 2023
8-K Current report
Officer or director change
Aug 24, 2023 Aug 23, 2023
8-K Current report
Other events
Aug 22, 2023 Aug 22, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
S-8 Employee stock plan registration May 16, 2023 —
10-Q Quarterly report May 15, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 15, 2023 May 15, 2023
8-K Current report
Officer or director change, Shareholder vote results
May 12, 2023 May 11, 2023
D/A Filing May 2, 2023 —
10-K/A Amended annual report Apr 7, 2023 Dec 31, 2022
ARS Annual report to shareholders Apr 4, 2023 Dec 31, 2022
DEF 14A Proxy statement Mar 31, 2023 Mar 31, 2023
DEFA14A Additional proxy material Mar 31, 2023 —
10-K Annual report Mar 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023
8-K Current report
Material agreement
Mar 15, 2023 Mar 13, 2023
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 10, 2023
S-8 Employee stock plan registration Mar 2, 2023 —
424B3 Prospectus Jan 12, 2023 —
EFFECT Filing Jan 11, 2023 —
CORRESP Letter to the SEC Jan 9, 2023 —
UPLOAD Letter from the SEC Jan 5, 2023 —
S-3 Shelf registration Dec 30, 2022 —
8-K Current report
New debt
Dec 23, 2022 Dec 22, 2022
D/A Filing Nov 28, 2022 —
D/A Filing Nov 28, 2022 —
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K/A Amended current report
Officer or director change
Nov 9, 2022 Nov 9, 2022
8-K Current report
Material agreement, Change to shareholder rights, Officer or director change
Sep 14, 2022 Sep 12, 2022
8-K Current report
Shareholder vote results
Sep 1, 2022 Sep 1, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Material agreement, Results of operations, New debt
Aug 11, 2022 Aug 9, 2022
8-K Current report
Material agreement
Jul 29, 2022 Jul 27, 2022
DEFA14A Additional proxy material Jul 19, 2022 —
DEF 14A Proxy statement Jul 19, 2022 Jul 19, 2022
PRE 14A Preliminary proxy statement Jul 7, 2022 Jul 7, 2022
S-8 Employee stock plan registration May 31, 2022 —
D Filing May 26, 2022 —
8-K Current report
Officer or director change
May 19, 2022 May 13, 2022
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
May 18, 2022 May 15, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Officer or director change, Shareholder vote results
May 16, 2022 May 12, 2022
DEF 14A Proxy statement Apr 11, 2022 Apr 11, 2022
D/A Filing Apr 8, 2022 —
PRE 14A Preliminary proxy statement Mar 30, 2022 Mar 30, 2022
10-K Annual report Mar 23, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 23, 2022 Mar 23, 2022
8-K Current report
Material agreement
Feb 4, 2022 Feb 4, 2022
424B5 Prospectus supplement Feb 4, 2022 —
EFFECT Filing Nov 26, 2021 —
CORRESP Letter to the SEC Nov 23, 2021 —
UPLOAD Letter from the SEC Nov 22, 2021 —
D/A Filing Nov 22, 2021 —
D/A Filing Nov 22, 2021 —
S-3 Shelf registration Nov 17, 2021 —
10-Q Quarterly report Nov 9, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 8, 2021 Nov 8, 2021
10-Q Quarterly report Aug 11, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Material agreement, Other events
Jun 30, 2021 Jun 28, 2021
424B5 Prospectus supplement Jun 29, 2021 —
424B5 Prospectus supplement Jun 28, 2021 —
S-8 Employee stock plan registration May 26, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
May 13, 2021 May 12, 2021
10-Q Quarterly report May 10, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 10, 2021 May 10, 2021
D Filing Apr 14, 2021 —
D Filing Apr 14, 2021 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Other events
Apr 8, 2021 Apr 8, 2021
EFFECT Filing Apr 5, 2021 —
CORRESP Letter to the SEC Mar 31, 2021 —
DEFA14A Additional proxy material Mar 31, 2021 —
DEF 14A Proxy statement Mar 31, 2021 May 12, 2021
UPLOAD Letter from the SEC Mar 26, 2021 —
S-3 Shelf registration Mar 23, 2021 —
S-8 Employee stock plan registration Mar 5, 2021 —
424B5 Prospectus supplement Feb 24, 2021 —
8-K Current report
Material agreement, Agreement ended, Other events
Feb 24, 2021 Feb 22, 2021
424B5 Prospectus supplement Feb 22, 2021 —
10-K Annual report Feb 16, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 16, 2021 Feb 16, 2021
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
D/A Filing Nov 2, 2020 —
D/A Filing Nov 2, 2020 —
10-Q/A Amended quarterly report Aug 11, 2020 Jun 30, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
424B5 Prospectus supplement Jun 5, 2020 —
8-K Current report
Material agreement
Jun 5, 2020 Jun 5, 2020
S-8 Employee stock plan registration May 29, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
May 15, 2020 May 14, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
DEFA14A Additional proxy material Mar 31, 2020 —
DEF 14A Proxy statement Mar 31, 2020 May 14, 2020
10-K Annual report Mar 13, 2020 Dec 31, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
CELC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Minneapolis, MN
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1603454
Former names
Celcuity LLC (until Sep 15, 2017)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.